What is the ISET® Blood Cytopathology technology?
The ISET® Technology is a highly sensitive diagnostic method identifying the presence of cancer cells in blood, based on a simple blood analysis. The presence of Cancer Cells in blood is, without any doubt, a sign of tumor invasion.
What does it detect?
By detecting tumor invasion in a highly sensitive and diagnostic manner, the ISET® Blood Cytopathology technology detects the risk of metastases years before they develop.
How can ISET® technology be used?
ISET® method can be used to obtain additional information for:
- Early identification of patients at risk of developing metastases,
- Monitoring the efficacy of cancer treatment.
Which are the types of cancer that can benefit from the ISET® Technology?
ISET® can isolate and identify CCC derived from all types of solid cancers with a diagnostic approach, thus meaning without mistakes. ISET® is not valid for leukemia and lymphoma.
When should I take it?
According to the advice of your Oncologist, you may take it:
- If you are a cancer survivor and want to stay alert for possible recurrences.
- If you are a cancer patient under chemotherapy, using this method will help your doctor assess if the treatment has been effective in killing the tumor cells.
- If you received a diagnosis of cancer and your oncologist recommends you a surveillance without any treatment.
Where can I take it?
How reliable are the results of ISET®?
The results of ISET® are highly reliable. The ISET® method is performed with high precision at each step:
- Very high sensitivity for isolation of any type of CCC from all types of solid cancers
- Diagnostic specificity ensured by the most reliable Cytopathologists at international level.